Haemonetics (HAE) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.40 +0.74%
Revenue Growth %: +5.5%
Financial Fact:
Net income: 0.39
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +5.5%
Financial Fact:
Net income: 0.39
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.99, $0.10 better than the analyst estimate of $0.89. Revenue for the quarter came in at $318.2 million versus the consensus estimate of $313.12 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Haemonetics to Buy, raises price target to $123
- Can global equities keep rising? UBS sees these factors driving upside
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
